Anika Therapeutics (ANIK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 100,156 | 63,333 | 44,068 | 35,777 | 28,202 |
| Marketable Securities | 6,750 | N/A | N/A | N/A | N/A |
| Receivables | 17,152 | 18,737 | 21,463 | 17,308 | 14,820 |
| Inventories | 12,407 | 10,997 | 8,284 | 7,303 | 8,950 |
| Income taxes - deferred | N/A | 659 | 2,032 | 1,919 | 1,991 |
| TOTAL | $137,836 | $94,592 | $77,385 | $64,138 | $56,322 |
| Non-Current Assets | |||||
| PPE Net | 31,669 | 32,939 | 35,113 | 36,470 | 36,981 |
| Intangibles | 23,234 | 28,442 | 29,401 | 32,032 | 34,856 |
| Other Non-Current Assets | 69 | 69 | 171 | 205 | 777 |
| TOTAL | $54,972 | $61,450 | $64,685 | $68,707 | $72,615 |
| Total Assets | $192,808 | $156,042 | $142,069 | $132,844 | $128,937 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,600 | 1,600 | 1,600 |
| Accounts payable and accrued liabilities | 1,201 | 2,794 | 2,342 | 4,300 | 9,694 |
| Accrued Expenses | 4,772 | 5,538 | 5,837 | 5,322 | 5,376 |
| TOTAL | $5,973 | $9,283 | $14,453 | $14,538 | $19,370 |
| Non-Current Liabilities | |||||
| Long Term Debt | 102 | N/A | 8,000 | 9,600 | 11,200 |
| Deferred Revenues | N/A | 180 | 2,875 | 2,867 | 2,700 |
| Other Non-Current Liabilities | 894 | 1,134 | 1,541 | 1,549 | 1,560 |
| TOTAL | $8,737 | $11,125 | $18,691 | $23,543 | $24,377 |
| Total Liabilities | $14,710 | $20,408 | $33,144 | $38,082 | $43,747 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,546 | 14,325 | 13,919 | 13,669 | 13,458 |
| Common Shares | 149 | 143 | 139 | 136 | 135 |
| Retained earnings | 104,904 | 66,584 | 46,010 | 34,252 | 25,786 |
| Other shareholders' equity | -4,495 | -1,699 | -2,655 | -3,067 | -2,548 |
| TOTAL | $178,098 | $135,634 | $108,925 | $94,763 | $85,190 |
| Total Liabilities And Equity | $192,808 | $156,042 | $142,069 | $132,845 | $128,937 |